ArticleFrontiers in public health2025
Monocarboxyoctyl phthalate is associated with platelet count: evidence from a large cross-sectional study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Phthalates are environmental pollutants that are harmful to human health. However, the impact of phthalate on platelet count remains unclear. This study aimed to examine the correlation between five phthalate metabolites in urine and platelet count, as well as the impact of phthalate metabolite exposure on platelet count in adults. Methods: This cross-sectional study included 11,409 non-pregnant participants aged >20 years using data available from the National Health and Nutrition Examination Survey (NHANES) between 2005 and 2018. Weighted logistic regression, restricted cubic spline (RCS) modeling, and weighted quantile sum (WQS) were employed to investigate the effects of mono-(carboxyisononyl) phthalate (MCNP), mono-(carboxyoctyl) phthalate (MCOP), mono-(3-carboxypropyl) phthalate (MCPP), mono-isobutyl phthalate (MiBP) and mono-isononyl phthalate (MNP) on platelet count. Results: Logistic regression analysis suggested that MCOP [odds ratio (OR) (95% confidence interval CI) = 0.009 (0.002-0.036)] was significantly associated with the platelet count. Subgroup analysis showed negative correlations between MCOP and platelet count across all age and sex groups, and MCNP [OR (95% CI) = 0.083(0.013-0.552)] displayed a negative association with platelet count in females. MCOP had a nonlinear relationship with the platelet count in the RCS model. WQS also revealed that MCOP was related to platelet count. Conclusion: Higher urinary MCOP level was associated with lower platelet count. Further investigation is necessary to substantiate these findings, considering the shortcomings of the NHANES study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.